Pérez-Jiménez EM, Velázquez-Santiago Y, Velázquez-Silva RI, Carpinteyro-Espín P, Serrano-Ortiz HJ, García-Flores OR, Vásquez-Jiménez EC, Ruelas-Román JP, Salgado-González FG, Rodríguez-Salinas CI, Cano-Gutiérrez VH, Román-López LP, Mendoza-Carrillo CA

Language: Spanish
References: 4
Page: 45-47
PDF size: 290. Kb.

ABSTRACT

In a post-transplant patient, the presence of anemia can vary depending on the definition used and the time of onset. Post-transplant anemia is generally a multifactorial process (drugs, infections, comorbidities). From an epidemiological standpoint, parvovirus B19 infection affects 40-60% of the population. Specifically in kidney transplantation, parvovirus B19 infection is a rare infectious complication. The presence of viral DNA has been demonstrated in the blood of 20-30% of transplant patients. The incidence of this virus in solid organ transplants is reported to be 2%. However, the exact incidence of infection in kidney transplants is unknown, although there are figures as high as 12%.

REFERENCES

1. Simunov B, Mrzljak A, Jurekovic Z, Zidovec Lepej S, Bainrauch A, Pavicic Saric J et al. Parvovirus B19 status in liver, kidney and pancreas transplant candidates: A single center experience. World J Transplant. 2022; 12 (11): 378-387.

2. Singh V, Dogra PM, Singh P, Singh SK, Ghosh I, Sreenivasa S et al. Parvovirus B19 infection after kidney transplantation: A single centre experience. Med J Armed Forces India. 2023; 79 (6): 665-671.

3. Choudry H, Chattah F, Shalla H, Ghulam F, Abbasi SH, Jesus-Silva J. Resistant anemia in a kidney transplant recipient: Pure red cell aplasia due to parvovirus B19 infection. Qatar Med J. 2024; 2024 (1): 8.

4. Zhong Q, Zeng J, Lin T, Song T. The detection, treatment of parvovirus B19 infection induced anemia in solid organ transplants: A case series and literature review of 194 patients. Transfus Clin Biol. 2022; 29 (2): 168-174.